Youqun Xiang

923 total citations
30 papers, 734 citations indexed

About

Youqun Xiang is a scholar working on Oncology, Molecular Biology and Toxicology. According to data from OpenAlex, Youqun Xiang has authored 30 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Toxicology. Recurrent topics in Youqun Xiang's work include Cytokine Signaling Pathways and Interactions (12 papers), Bioactive Compounds and Antitumor Agents (8 papers) and Cancer-related molecular mechanisms research (5 papers). Youqun Xiang is often cited by papers focused on Cytokine Signaling Pathways and Interactions (12 papers), Bioactive Compounds and Antitumor Agents (8 papers) and Cancer-related molecular mechanisms research (5 papers). Youqun Xiang collaborates with scholars based in China, United States and Ireland. Youqun Xiang's co-authors include Chengguang Zhao, Xuanxuan Dai, Lehe Yang, Guang Liang, Lingyuan Xu, Xiaoying Huang, Haiyang Zhao, Liangxing Wang, Ruimin Ma and Jifa Li and has published in prestigious journals such as Oncogene, British Journal of Cancer and Medicine.

In The Last Decade

Youqun Xiang

30 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youqun Xiang China 17 347 250 150 84 73 30 734
Xufeng Guo China 16 276 0.8× 135 0.5× 108 0.7× 123 1.5× 98 1.3× 37 733
Hongfei Tong China 18 392 1.1× 133 0.5× 141 0.9× 55 0.7× 99 1.4× 36 867
Liangliang Bai China 17 348 1.0× 251 1.0× 156 1.0× 58 0.7× 141 1.9× 51 838
Olivia Aranha United States 13 398 1.1× 213 0.9× 76 0.5× 83 1.0× 54 0.7× 34 676
Shafquat Azim United States 12 275 0.8× 153 0.6× 126 0.8× 52 0.6× 46 0.6× 25 554
Sakshi Sikka Singapore 7 531 1.5× 368 1.5× 167 1.1× 132 1.6× 59 0.8× 8 904
Itishree Kaushik United States 10 435 1.3× 212 0.8× 156 1.0× 65 0.8× 90 1.2× 12 756
Jiao Li China 16 392 1.1× 107 0.4× 132 0.9× 60 0.7× 68 0.9× 31 686
Jiege Huo China 19 403 1.2× 229 0.9× 147 1.0× 62 0.7× 99 1.4× 56 836
Virginie Poindessous France 17 484 1.4× 282 1.1× 187 1.2× 61 0.7× 123 1.7× 32 837

Countries citing papers authored by Youqun Xiang

Since Specialization
Citations

This map shows the geographic impact of Youqun Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youqun Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youqun Xiang more than expected).

Fields of papers citing papers by Youqun Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youqun Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youqun Xiang. The network helps show where Youqun Xiang may publish in the future.

Co-authorship network of co-authors of Youqun Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Youqun Xiang. A scholar is included among the top collaborators of Youqun Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youqun Xiang. Youqun Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yanan, Liting Zhang, Xiaolu Chen, et al.. (2022). The novel FGFR inhibitor F1-7 induces DNA damage and cell death in colon cells. British Journal of Cancer. 127(6). 1014–1025. 4 indexed citations
2.
Liu, Shuanghui, Rui Zhang, Yajiao Wang, et al.. (2022). HOXA13 serves as a biomarker to predict neoadjuvant therapy efficacy in advanced colorectal cancer patients. Acta Biochimica et Biophysica Sinica. 55(2). 304–313. 5 indexed citations
3.
Chen, Xiaotian, Zhewei Zhang, Tingting Cai, et al.. (2022). Nomogram based on intramuscular adipose tissue content for predicting the prognosis of patients with gallbladder cancer after radical resection. Translational Cancer Research. 11(7). 1898–1908. 7 indexed citations
4.
Zheng, Dandan, Yu Zhu, Lehe Yang, et al.. (2021). Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis. Frontiers in Cell and Developmental Biology. 8. 605184–605184. 17 indexed citations
5.
Zhao, Chengguang, Lehe Yang, Feng Zhou, et al.. (2020). Feedback activation of EGFR is the main cause for STAT3 inhibition-irresponsiveness in pancreatic cancer cells. Oncogene. 39(20). 3997–4013. 28 indexed citations
6.
Yang, Lehe, Ying Bai, Dandan Zheng, et al.. (2020). Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway. Phytomedicine. 80. 153366–153366. 24 indexed citations
7.
Yang, Lehe, Yan Zhuang, Yanan Liu, et al.. (2020). Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway. British Journal of Cancer. 124(3). 645–657. 48 indexed citations
8.
Yang, Lehe, Jifa Li, Lingyuan Xu, et al.. (2019). <p>Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway</p>. Cancer Management and Research. Volume 11. 1167–1176. 45 indexed citations
9.
Yang, Lehe, Lingyuan Xu, Youqun Xiang, et al.. (2019). Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy. Journal of Experimental & Clinical Cancer Research. 38(1). 293–293. 61 indexed citations
10.
Xu, Lingyuan, et al.. (2019). <p>Design, Synthesis, And Evaluation Of Cyanopyridines As Anti-Colorectal Cancer Agents Via Inhibiting STAT3 Pathway</p>. Drug Design Development and Therapy. Volume 13. 3369–3381. 21 indexed citations
11.
Yang, Lehe, Youqun Xiang, Lingyuan Xu, et al.. (2019). Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 31–31. 74 indexed citations
12.
Zheng, Hailun, Lehe Yang, Min Chen, et al.. (2018). Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling. Molecular Carcinogenesis. 58(4). 565–576. 53 indexed citations
13.
Yang, Lehe, Youqun Xiang, Wanle Hu, et al.. (2018). L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway. Cancer Management and Research. Volume 10. 565–581. 14 indexed citations
14.
Dai, Xuanxuan, Changtian Yin, Yi Zhang, et al.. (2018). Osthole inhibits triple negative breast cancer cells by suppressing STAT3. Journal of Experimental & Clinical Cancer Research. 37(1). 322–322. 68 indexed citations
15.
Ma, Ruimin, et al.. (2016). Utility of Red Cell Distribution Width as a Prognostic Factor in Young Breast Cancer Patients. Medicine. 95(17). e3430–e3430. 41 indexed citations
16.
Xiang, Youqun, Yinlong Yang, Gui-Long Guo, et al.. (2015). β3-tubulin is a good predictor of sensitivity to taxane-based neoadjuvant chemotherapy in primary breast cancer. Clinical and Experimental Medicine. 16(3). 391–397. 4 indexed citations
17.
Ye, Tingting, et al.. (2014). Prognostic value of circulating microRNA-21 in digestive system cancers: a meta-analysis.. PubMed. 7(4). 873–8. 5 indexed citations
18.
Xiang, Youqun, et al.. (2014). Thymectomy in central lymph node dissection for papillary thyroid cancer.. PubMed. 7(4). 1135–9. 6 indexed citations
19.
Huang, Ou, Weili Wu, Ouchen Wang, et al.. (2011). Sentinel lymph node biopsy is unsuitable for routine practice in younger female patients with unilateral low-risk papillary thyroid carcinoma. BMC Cancer. 11(1). 386–386. 24 indexed citations
20.
Zhang, Xiaohua, et al.. (2010). Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer. Journal of Cancer Research and Clinical Oncology. 136(9). 1349–1357. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xufeng Guo Breakdown of academic impact, for papers by Hongfei Tong Breakdown of academic impact, for papers by Liangliang Bai Breakdown of academic impact, for papers by Olivia Aranha Breakdown of academic impact, for papers by Shafquat Azim Breakdown of academic impact, for papers by Sakshi Sikka Breakdown of academic impact, for papers by Itishree Kaushik Breakdown of academic impact, for papers by Jiao Li Breakdown of academic impact, for papers by Jiege Huo Breakdown of academic impact, for papers by Virginie Poindessous
Rankless by CCL
2026